National Pharma Cold-Chain Network

01 / Corporate and sponsor report

Example entry: Applicant legal entity: to be provided by the buyer. Jurisdiction, registration number, beneficial ownership, authorized signatories and corporate group structure: pending documentation. ColdMatch is the specialist routing destination for this scope, not the buyer or its legal sponsor.

The file should attach registration and ownership documents, evidence of authority to request proposals, sponsor accounts where available, and a named decision owner. The reviewer records what has been received, what remains open and whether disclosure to potential suppliers is authorized. No supplier outreach follows until human review.

02 / Project description and technical scope

Example entry: National Pharma Cold-Chain Network. The buyer states the site, product, required output and operating assumptions; these inputs remain open until confirmed. The first tender schedule separates work package 1 from work package 2, rather than asking suppliers for one unexplained total.

Scope excerpt — Work package 1: Six regional cold-hub design and equipment tender Record the technical specification, battery limits, utilities and acceptance test for this package; assign responsibility for its interface with the next package.

The annex should identify site constraints, local permits, installation and commissioning responsibilities, warranty boundaries and evaluation criteria. Missing capacity, site or utility information is flagged for the buyer rather than filled with assumptions.

03 / Financing-readiness report

Example entry: Funding requirement: not stated; buyer equity contribution: not stated; debt request: not stated. The cost schedule distinguishes equipment, freight and duties, civil works, installation, commissioning, contingency and initial working capital. Supplier quotations and a cash-flow model are required before calculating a funding gap or debt-service capacity.

Routes for preliminary screening include equipment finance subject to independent provider assessment and buyer or supplier credit subject to eligibility. These are options to assess, not available facilities. A provider will independently test sponsor strength, equipment origin, permits, contracts and repayment assumptions. Global B2B Group is not a lender, insurer or financing approver.

04 / CAPEX approval memorandum

Example recommendation: Hold the investment decision pending a confirmed budget, like-for-like supplier bids and a documented funding plan. Show the base case, contingency, total installed cost, operating assumptions and an alternative to proceeding. No board decision or approved amount is implied by this example.

Risk-register excerpt: Scope and supplier interfaces are not yet validated for this report example. Proposed control: Confirm technical boundaries and ownership of each interface with the buyer before tender. Assign an owner and evidence deadline before the approval meeting.

Approval gates: technical scope signed off by the buyer; commercial comparison and exclusions reviewed; funding source confirmed by the relevant decision-maker; permits and delivery dependencies assessed; board or investment committee resolution recorded. Only the buyer can approve its CAPEX.